Skip to main content

Pfizer — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

100
Companies
$4.7B
Total invested
$93.8M
Avg. check
24
Industries
Biotechnology 21Health Care 14Therapeutics 13Medical 8Pharmaceutical 8Biopharma 6+18 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 100
Dren Bio
October 2026

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Biotechnology · San Carlos$350.0M Venture - Series Unknown
Circle Pharma
September 2026

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

Biotechnology · San Francisco$92.5M Series E
TwoStep Therapeutics
September 2026

TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.

Biotechnology · Palo Alto$62.5M Series A
Spero Therapeutics
July 2026

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Biotechnology · Cambridge$105.0M Post-IPO Debt
Engine Biosciences
June 2026

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI) · SingaporeVenture - Series Unknown
Oblenio Bio
June 2026

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Biopharma · Oakland$62.0M Series B
Cour Pharmaceuticals Development
June 2026

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Biotechnology · Skokie$50.0M Series B
Quince Therapeutics
May 2026

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Biotechnology · South San Francisco$115.0M Post-IPO Equity
Valneva
April 2026

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Biotechnology · Saint-herblain$43.1M Post-IPO Equity
Allogene Therapeutics
April 2026

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Biotechnology · South San Francisco$200.4M Post-IPO Equity
DAIVIN
March 2026

Daivin is an oxygen-generating equipment manufacturing company which helps humans breathe underwater without oxygen tanks.

Aerospace · San FranciscoPre-Seed
MindImmune Therapeutics
March 2026

MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.

Biotechnology · Providence$5.0M Grant
Enodia Therapeutics
January 2026

Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.

Biotechnology · Paris$24.2M Seed
FoRx Therapeutics
December 2025

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

Biotechnology · Basel$50.0M Series A
NextCure
November 2025

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Biopharma · Beltsville$21.5M Post-IPO Equity
HealthTech Innovations
October 2025

HealthTech Innovations is a spin-off of Hospital Germans Trias i Pujol and transforming medical care through virtual reality.

Consulting · Barcelona$930K Seed
ReCode Therapeutics
September 2025

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Biopharma · Dallas$29.4M Debt Financing
Resistell AG
September 2025

Resistell is a antibiotic resistance test.

Health Diagnostics · BaselGrant
Rhythm Pharmaceuticals
July 2025

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Biotechnology · Boston$175.0M Post-IPO Equity
ORIC Pharmaceuticals
May 2025

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Biopharma · South San Francisco$125.0M Post-IPO Equity
EvolveImmune Therapeutics
October 2024

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

Biotechnology · Branford$20.0M Venture - Series Unknown
AgomAb Therapeutics
October 2024

Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.

Biotechnology · Antwerpen$88.7M Series D
Enara Bio
October 2024

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Biopharma · Oxford$32.5M Series B
CytoReason
July 2024

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Biopharma · Tel Aviv$80.0M Series B

Where Pfizer invests

Biotechnology21
Health Care14
Therapeutics13
Medical8
Pharmaceutical8
Biopharma6

About Pfizer's portfolio

How many companies has Pfizer invested in?▸

Pfizer has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Pfizer invest in?▸

Pfizer's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 24 different industry categories.

What is Pfizer's largest investment?▸

Among tracked funding rounds, Dren Bio received $350.0M in a Venture - Series Unknown round. Pfizer's total known invested capital is $4.7B.

What is the average investment size for Pfizer?▸

Pfizer's average investment size is $93.8M across its portfolio of 100 companies.

What are Pfizer's most recent investments?▸

Recent Pfizer portfolio additions include Dren Bio, Circle Pharma, TwoStep Therapeutics, Spero Therapeutics, Engine Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 100 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →